These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 31193785)

  • 1. Neutrophil-mimicking therapeutic nanoparticles for targeted chemotherapy of pancreatic carcinoma.
    Cao X; Hu Y; Luo S; Wang Y; Gong T; Sun X; Fu Y; Zhang Z
    Acta Pharm Sin B; 2019 May; 9(3):575-589. PubMed ID: 31193785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation-Targeted Delivery of Celastrol via Neutrophil Membrane-Coated Nanoparticles in the Management of Acute Pancreatitis.
    Zhou X; Cao X; Tu H; Zhang ZR; Deng L
    Mol Pharm; 2019 Mar; 16(3):1397-1405. PubMed ID: 30753778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bio-Mimicking Nanoparticles for Targeted Therapy of Malignant Melanoma.
    Zhou X; Yu R; Cao X; Zhang ZR; Deng L
    J Biomed Nanotechnol; 2019 May; 15(5):993-1004. PubMed ID: 30890230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferential tumor accumulation and desirable interstitial penetration of poly(lactic-co-glycolic acid) nanoparticles with dual coating of chitosan oligosaccharide and polyethylene glycol-poly(D,L-lactic acid).
    Wang G; Chen Y; Wang P; Wang Y; Hong H; Li Y; Qian J; Yuan Y; Yu B; Liu C
    Acta Biomater; 2016 Jan; 29():248-260. PubMed ID: 26476340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracisternal administration of tanshinone IIA-loaded nanoparticles leads to reduced tissue injury and functional deficits in a porcine model of ischemic stroke.
    Waters ES; Kaiser EE; Yang X; Fagan MM; Scheulin KM; Jeon JH; Shin SK; Kinder HA; Kumar A; Platt SR; Duberstein KJ; Park HJ; Xie J; West FD
    IBRO Neurosci Rep; 2021 Jun; 10():18-30. PubMed ID: 33842909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced application of stimuli-responsive drug delivery system for inflammatory arthritis treatment.
    Zhang M; Hu W; Cai C; Wu Y; Li J; Dong S
    Mater Today Bio; 2022 Mar; 14():100223. PubMed ID: 35243298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and characterization of sorafenib-loaded PLGA nanoparticles for the systemic treatment of liver fibrosis.
    Lin TsT; Gao DY; Liu YC; Sung YC; Wan D; Liu JY; Chiang T; Wang L; Chen Y
    J Control Release; 2016 Jan; 221():62-70. PubMed ID: 26551344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of PEGylation on an antibody-loaded nanoparticle-based drug delivery system for the treatment of inflammatory bowel disease.
    Shrestha N; Xu Y; Prévost JRC; McCartney F; Brayden D; Frédérick R; Beloqui A; Préat V
    Acta Biomater; 2022 Mar; 140():561-572. PubMed ID: 34923097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil membrane-coated nanoparticles exhibit increased antimicrobial activities in an anti-microbial resistant K. pneumonia infection model.
    Liu J; Chen X; Xu L; Tu F; Rui X; Zhang L; Yan Z; Liu Y; Hu R
    Nanomedicine; 2023 Feb; 48():102640. PubMed ID: 36549558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Fluorouracil-loaded PLA/PLGA PEG-PPG-PEG polymeric nanoparticles: formulation, in vitro characterization and cell culture studies.
    Ocal H; Arica-Yegin B; Vural I; Goracinova K; Caliş S
    Drug Dev Ind Pharm; 2014 Apr; 40(4):560-7. PubMed ID: 23596973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mithramycin-loaded mPEG-PLGA nanoparticles exert potent antitumor efficacy against pancreatic carcinoma.
    Liu XJ; Li L; Liu XJ; Li Y; Zhao CY; Wang RQ; Zhen YS
    Int J Nanomedicine; 2017; 12():5255-5269. PubMed ID: 28769562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and mechanistic insight into enhanced cytotoxic potential of hyaluronic acid conjugated nanoparticles in CD44 overexpressing cancer cells.
    Saneja A; Nayak D; Srinivas M; Kumar A; Khare V; Katoch A; Goswami A; Vishwakarma RA; Sawant SD; Gupta PN
    Eur J Pharm Sci; 2017 Jan; 97():79-91. PubMed ID: 27989859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon.
    Wu P; Zhou Q; Zhu H; Zhuang Y; Bao J
    BMC Cancer; 2020 Apr; 20(1):354. PubMed ID: 32345258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donepezil loaded PLGA-b-PEG nanoparticles: their ability to induce destabilization of amyloid fibrils and to cross blood brain barrier in vitro.
    Baysal I; Ucar G; Gultekinoglu M; Ulubayram K; Yabanoglu-Ciftci S
    J Neural Transm (Vienna); 2017 Jan; 124(1):33-45. PubMed ID: 26911385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of α-tocopherol surface-modified targeted delivery of 5-fluorouracil-loaded poly-D, L-lactic-co-glycolic acid nanoparticles against oral squamous cell carcinoma.
    Srivastava S; Gupta S; Mohammad S; Ahmad I
    J Cancer Res Ther; 2019; 15(3):480-490. PubMed ID: 31169208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil.
    Yadav AK; Agarwal A; Rai G; Mishra P; Jain S; Mishra AK; Agrawal H; Agrawal GP
    Drug Deliv; 2010 Nov; 17(8):561-72. PubMed ID: 20738221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and evaluation of long-circulating nanoparticles loaded with betulinic acid for improved anti-tumor efficacy.
    Saneja A; Kumar R; Singh A; Dhar Dubey R; Mintoo MJ; Singh G; Mondhe DM; Panda AK; Gupta PN
    Int J Pharm; 2017 Oct; 531(1):153-166. PubMed ID: 28823888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticles design considerations to co-deliver nucleic acids and anti-cancer drugs for chemoresistance reversal.
    Eljack S; David S; Faggad A; Chourpa I; Allard-Vannier E
    Int J Pharm X; 2022 Dec; 4():100126. PubMed ID: 36147518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-delivery of sorafenib and metapristone encapsulated by CXCR4-targeted PLGA-PEG nanoparticles overcomes hepatocellular carcinoma resistance to sorafenib.
    Zheng N; Liu W; Li B; Nie H; Liu J; Cheng Y; Wang J; Dong H; Jia L
    J Exp Clin Cancer Res; 2019 May; 38(1):232. PubMed ID: 31151472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
    Hadinoto K; Sundaresan A; Cheow WS
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.